Dietary advanced glycation end-products aggravate non-alcoholic fatty liver disease

doi:10.3748/wjg.v22.i35.8026

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 22, Issue 35

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (13516)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series, Tables (1-2) series.

Item

Count

PDF

834

WORD

269

HTML

7570

Figures (1-5)

377

Tables (1-2)

520

Sum=9570

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1342

Download

2604

Sum=3946

Sep 21, 2016 (publication date) through Dec 25, 2024

Times Cited of This Article

Times Cited (58)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastroenterol. Sep 21, 2016; 22(35): 8026-8040
Published online Sep 21, 2016. doi: 10.3748/wjg.v22.i35.8026

Full Size Figure Download Figure

Figure 4 Effects of advanced glycation end products on reactive oxygen species and proliferation in isolated Kupffer cells exposed to physiological amounts of dietary advanced glycation end products compared with bovine serum albumin vehicle. A: Advanced glycation end products (AGEs) increased ROS generation as measured by 2’,7’-dichlorodihydrofluorescein diacetate. B: AGEs increased cell proliferation as assessed by BrDU incorporation, ^aP≤ 0.05.

Citation: Leung C, Herath CB, Jia Z, Andrikopoulos S, Brown BE, Davies MJ, Rivera LR, Furness JB, Forbes JM, Angus PW. Dietary advanced glycation end-products aggravate non-alcoholic fatty liver disease. World J Gastroenterol 2016; 22(35): 8026-8040
URL: https://www.wjgnet.com/1007-9327/full/v22/i35/8026.htm
DOI: https://dx.doi.org/10.3748/wjg.v22.i35.8026